HRT Financial’s China Biologic Products Holdings, Inc. CBPO Stock Holding History

HRT Financial’s Portfolio CBPO Stock Details CBPO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-5,288	Closed	-$626K	–	3877
2021 Q1	$626K	Sell	5,288 -8,278	-61%	-$979K	0.01%	1611
2020 Q4	$1.6M	Buy	+13,566	New	+$1.58M	0.03%	401

HRT Financial's CBPO Position: Q2 2021 in Review

HRT Financial sold out of China Biologic Products Holdings, Inc. (CBPO) in Q2 2021, closing a stake of 5,288 shares — an estimated $626K sold.

HRT Financial first reported a position in CBPO in Q4 2020 and held it in 2 quarters. The position peaked at $1.6M in Q4 2020. 0 funds tracked by Wall St. Rank hold CBPO as of Q2 2021.

HRT Financial reported no remaining China Biologic Products Holdings, Inc. position as of Q2 2021 after selling out during the quarter.
HRT Financial sold 5,288 China Biologic Products Holdings, Inc. shares in Q2 2021, an estimated $626K.
HRT Financial first reported a position in China Biologic Products Holdings, Inc. in Q4 2020 and held it in 2 quarters.
HRT Financial's China Biologic Products Holdings, Inc. position peaked at $1.6M in Q4 2020.
0 funds tracked by Wall St. Rank held China Biologic Products Holdings, Inc. as of Q2 2021.

Based on HRT Financial's 13F filing for Q2 2021, filed 16 Aug 2021.